Company profile: SEPS Pharma
1.1 - Company Overview
Company description
- Provider of drug product development services, encompassing preformulation and formulation development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SEPS Pharma
Comecer
HQ: Italy
Website
- Description: Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comecer company profile →
US BioTek
HQ: United States
Website
- Description: Provider of CLIA-accredited immunology and chemistry testing services for clinicians worldwide, including food sensitivity (IgG, IgG4, IgA), food allergy (IgE), inhalant/aeroallergen (IgG, IgG4, IgA, IgE), microbiome, organic acids, and environmental pollutants testing, backed by over 30 years of experience in ELISA technology. Headquartered in Shoreline, Washington.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US BioTek company profile →
Spatial Transcriptomics
HQ: Sweden
Website
- Description: Provider of technology to perform RNA sequencing in 2D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spatial Transcriptomics company profile →
Mission Bio
HQ: United States
Website
- Description: Provider of a single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development, offering the Tapestri Platform for DNA and protein analysis to detect rare clonal populations, custom assay development, single-cell analysis services for therapeutic development, and sample multiplexing to increase throughput and reduce costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mission Bio company profile →
Mologic
HQ: United Kingdom
Website
- Description: Provider of point-of-care diagnostic solutions, offering contract research for assay and antibody development, flexible manufacturing of lateral flow diagnostics, and a portfolio of rapid tests for health issues including yellow fever and chronic obstructive pulmonary disorder. Also partners with governments and organizations to distribute diagnostics globally, focusing on areas with significant need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mologic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SEPS Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SEPS Pharma
2.2 - Growth funds investing in similar companies to SEPS Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SEPS Pharma
4.2 - Public trading comparable groups for SEPS Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →